Cite
HARVARD Citation
Chugh, Y. et al. (2023). Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real‐world analysis. Pacing and clinical electrophysiology. 46 (1), pp. 50-58. [Online].